MeiraGTx Holdings plc (MGTX) Reports Clinical Data on Botare

MeiraGTx Holdings plc (MGTX) Reports Clinical Data on Botaretigene Sparoparvovec for the Treatment of X-Linked Retinitis Pigmentosa

MeiraGTx Holdings plc (MGTX) Reports Clinical Data on Botaretigene Sparoparvovec for the Treatment of X-Linked Retinitis Pigmentosa

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Colorado , United States , Denver , Paule Sladen , Michel Michaelides , Meiragtx Holdings , Institute Of Ophthalmology , Janssen Pharmaceuticals Inc , Janssen Pharmaceutical Companies Of Johnson , Association For Research , Nasdaq , X Linked Retinitis Pigmentosa , Professor Michel , Presentation Details , Gene Therapy , Demonstrates Localized Improvements , Static Perimetrypresenter , Associatedx Linked Retinitis Pigmentosa , Presenting Author , Janssen Pharmaceuticals , Janssen Pharmaceutical Companies ,